<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04816994</url>
  </required_header>
  <id_info>
    <org_study_id>0092-17-HMO</org_study_id>
    <nct_id>NCT04816994</nct_id>
  </id_info>
  <brief_title>Effect of Cannabis Extract on Acute Radicular Pain and on Analgesic Requirement</brief_title>
  <official_title>Effect of Cannabis Extract on Acute Radicular Pain and on Analgesic Requirement: A Double Blinded, Randomized, 24 Hours Follow-up Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical evidence about the effects of cannabis in the management of acute pain is rather&#xD;
      scarce, mostly consisting of case report-based opinions on adverse events during or after&#xD;
      general anesthesia after smoking cannabis, experimental pain trials in healthy volunteers,&#xD;
      and a few clinical trials using different drugs, dosages and routes of administration. It is&#xD;
      difficult to draw strong conclusions from the available evidence, that may seem sometimes&#xD;
      even contradictory, mainly due -the investigators believe- to the many sources of variability&#xD;
      in the study designs (e.g.: heterogeneity of the study samples, underpowered, unblinding,&#xD;
      lack of randomization, timing of the therapeutic intervention, different experimental pain&#xD;
      models, inclusion of different kind of surgical pain, etc.). Nevertheless, expert's opinion&#xD;
      after a critical review of the literature is that cannabis and cannabinoids may have a&#xD;
      beneficial role in the management of acute pain, at least for a selected group of patients&#xD;
      and through an appropriate therapeutic intervention.&#xD;
&#xD;
      Cannabis oil seem to be most suitable to our investigation. The co-administration of&#xD;
      tetrahydrocannabinol (THC) with cannabidiol (CBD) may translate into additional therapeutic&#xD;
      benefits with an attenuation of adverse effects. And will help treat acute radicular back&#xD;
      pain&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 7, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Radicular pain- VAS</measure>
    <time_frame>The change over 24 hours</time_frame>
    <description>Self-reported visual analog scale (VAS 0 - 100 mm) at rest and on movement.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>opioid consumption via - Patient controlled administration (PCA)</measure>
    <time_frame>The change over 24 hours</time_frame>
    <description>Count of patient-controlled analgesia pushes.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nausea and vomiting (PONV) score</measure>
    <time_frame>The change over 24 hours</time_frame>
    <description>PONV score (0 - 4). Before administering baseline, after 0.5, 1, 2, 4, 8 12, 18, 24 h.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety - VAS</measure>
    <time_frame>The change over 24 hours</time_frame>
    <description>Self-assessed anxiety visual analog scale (0-100 mm). Before administering baseline, after 0.5, 1, 2, 4, 8 12, 18, 24 h.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Acute Radicular Back Pain</condition>
  <condition>Cannabis</condition>
  <arm_group>
    <arm_group_label>High dose cannabis oil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single-dose 20.0 mg tetrahydrocannabinol + 20 mg cannabidiol, Sub-linguistic.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low dose cannabis oil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single-dose 10 mg tetrahydrocannabinol + 10 mg cannabidiol, Sub-linguistic.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Single-dose Olive oil that is similar in appearance and taste to cannabis oil</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Single-dose of cannabis oil</intervention_name>
    <description>Single-dose of cannabis oil in order to treat acute radicular pain</description>
    <arm_group_label>High dose cannabis oil</arm_group_label>
    <arm_group_label>Low dose cannabis oil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Giving a sub-linguistic olive oil that is similar in appearance and taste to cannabis oil</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18 - 70 years&#xD;
&#xD;
          -  ASA 1 or 2&#xD;
&#xD;
          -  Acute Radicular Pain &lt; 12 weeks&#xD;
&#xD;
          -  Pain of VAS 6 or more/ VRS moderate or more&#xD;
&#xD;
          -  Radicular pain: Dermatomal pain that corresponds to physical exam and CT/MRI in the&#xD;
             last year&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 18 or &gt; 70 years&#xD;
&#xD;
          -  ASA 3 or more&#xD;
&#xD;
          -  Chronic radicular pain &gt; 12 weeks&#xD;
&#xD;
          -  Past spine surgery&#xD;
&#xD;
          -  Intermittent Claudication due to Vascular Disease&#xD;
&#xD;
          -  Diagnosed Diabetic Neuropathy&#xD;
&#xD;
          -  Regular Cannabis use in past 6 months (more than once a week) OR once in last 2 weeks&#xD;
&#xD;
          -  Regular opioid use in past week (Targin, Percocet, Tramadol) (Equivalent to Oxycodone&#xD;
             20 mg/day or more)&#xD;
&#xD;
          -  Pregnancy or Lactating&#xD;
&#xD;
          -  Ischemic heart disease&#xD;
&#xD;
          -  Renal or hepatic failure&#xD;
&#xD;
          -  History of psychiatric illness&#xD;
&#xD;
          -  Cognitive impairment or inability to answer questions&#xD;
&#xD;
          -  Known allergy to opioids&#xD;
&#xD;
          -  Potential Loss to follow up&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hadassah Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elyad M Davidson, M.D</last_name>
      <phone>972-2-6776911</phone>
      <phone_ext>54211</phone_ext>
      <email>edavidson@hadassah.org.il</email>
    </contact>
    <investigator>
      <last_name>Elyad M Davidson, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>February 8, 2021</study_first_submitted>
  <study_first_submitted_qc>March 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 25, 2021</study_first_posted>
  <last_update_submitted>March 24, 2021</last_update_submitted>
  <last_update_submitted_qc>March 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hadassah Medical Organization</investigator_affiliation>
    <investigator_full_name>Elyad Davidson</investigator_full_name>
    <investigator_title>Director Pain Relief Unit</investigator_title>
  </responsible_party>
  <keyword>Acute radicular back pain</keyword>
  <keyword>Cannabis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Marijuana Abuse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

